• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多能细胞中的全基因组筛选确定 Mtf1 是突变型亨廷顿毒性的抑制剂。

Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.

机构信息

Department of Molecular Medicine, Medical School, University of Padua, 35131, Padua, Italy.

Aptuit (Verona) S.r.l., an Evotec Company, Campus Levi-Montalcini, 37135, Verona, Italy.

出版信息

Nat Commun. 2023 Jul 5;14(1):3962. doi: 10.1038/s41467-023-39552-9.

DOI:10.1038/s41467-023-39552-9
PMID:37407555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10322923/
Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by CAG-repeat expansions in the huntingtin (HTT) gene. The resulting mutant HTT (mHTT) protein induces toxicity and cell death via multiple mechanisms and no effective therapy is available. Here, we employ a genome-wide screening in pluripotent mouse embryonic stem cells (ESCs) to identify suppressors of mHTT toxicity. Among the identified suppressors, linked to HD-associated processes, we focus on Metal response element binding transcription factor 1 (Mtf1). Forced expression of Mtf1 counteracts cell death and oxidative stress caused by mHTT in mouse ESCs and in human neuronal precursor cells. In zebrafish, Mtf1 reduces malformations and apoptosis induced by mHTT. In R6/2 mice, Mtf1 ablates motor defects and reduces mHTT aggregates and oxidative stress. Our screening strategy enables a quick in vitro identification of promising suppressor genes and their validation in vivo, and it can be applied to other monogenic diseases.

摘要

亨廷顿病(HD)是一种由亨廷顿(HTT)基因中的 CAG 重复扩展引起的神经退行性疾病。由此产生的突变 HTT(mHTT)蛋白通过多种机制诱导毒性和细胞死亡,目前尚无有效的治疗方法。在这里,我们在多能小鼠胚胎干细胞(ESCs)中进行了全基因组筛选,以鉴定 mHTT 毒性的抑制剂。在所鉴定的抑制剂中,我们关注与 HD 相关过程相关的金属反应元件结合转录因子 1(Mtf1)。Mtf1 的强制表达可抵抗 mHTT 在小鼠 ESCs 和人神经前体细胞中引起的细胞死亡和氧化应激。在斑马鱼中,Mtf1 可减少 mHTT 引起的畸形和细胞凋亡。在 R6/2 小鼠中,Mtf1 消除了运动缺陷,并减少了 mHTT 聚集体和氧化应激。我们的筛选策略能够快速在体外鉴定有前途的抑制剂基因,并在体内进行验证,它可以应用于其他单基因疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/84824388cbfb/41467_2023_39552_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/edd25fddfc01/41467_2023_39552_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/f80ed239e902/41467_2023_39552_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/c8cd9b8148e8/41467_2023_39552_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/4bbaf64c4ceb/41467_2023_39552_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/2adb33361436/41467_2023_39552_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/5a8788b5d6d0/41467_2023_39552_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/9dc525d4afe6/41467_2023_39552_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/84824388cbfb/41467_2023_39552_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/edd25fddfc01/41467_2023_39552_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/f80ed239e902/41467_2023_39552_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/c8cd9b8148e8/41467_2023_39552_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/4bbaf64c4ceb/41467_2023_39552_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/2adb33361436/41467_2023_39552_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/5a8788b5d6d0/41467_2023_39552_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/9dc525d4afe6/41467_2023_39552_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7da/10322923/84824388cbfb/41467_2023_39552_Fig8_HTML.jpg

相似文献

1
Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.在多能细胞中的全基因组筛选确定 Mtf1 是突变型亨廷顿毒性的抑制剂。
Nat Commun. 2023 Jul 5;14(1):3962. doi: 10.1038/s41467-023-39552-9.
2
A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.一种新型的人胚胎干细胞源性亨廷顿病神经元模型表现出突变型亨廷顿蛋白(mHTT)聚集和可溶性 mHTT 依赖性神经退行性变。
FASEB J. 2013 May;27(5):1820-9. doi: 10.1096/fj.12-219220. Epub 2013 Jan 16.
3
Neuroprotective Effects of σR/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.σR/TMEM97 受体调节剂在亨廷顿病神经元模型中的神经保护作用。
ACS Chem Neurosci. 2022 Oct 5;13(19):2852-2862. doi: 10.1021/acschemneuro.2c00274. Epub 2022 Sep 15.
4
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.小分子蛋白二硫键异构酶调节剂可减轻亨廷顿病模型小鼠中突变型亨廷顿蛋白的毒性,并抑制内质网应激。
Hum Mol Genet. 2018 May 1;27(9):1545-1555. doi: 10.1093/hmg/ddy061.
5
MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.微小RNA-27a在亨廷顿舞蹈症的体外模型中减少突变型亨廷顿蛋白的聚集。
Biochem Biophys Res Commun. 2017 Jun 24;488(2):316-321. doi: 10.1016/j.bbrc.2017.05.040. Epub 2017 May 8.
6
RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.RTP801参与突变亨廷顿蛋白诱导的细胞死亡。
Mol Neurobiol. 2016 Jul;53(5):2857-2868. doi: 10.1007/s12035-015-9166-6. Epub 2015 Apr 16.
7
Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading.R6/1 亨廷顿病(HD)小鼠视网膜中的髓鞘小体细胞器:普遍分布及其在疾病传播中的可能作用。
Int J Mol Sci. 2021 Nov 25;22(23):12771. doi: 10.3390/ijms222312771.
8
Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.调节 FKBP5/FKBP51 和自噬可降低 HTT(亨廷顿蛋白)水平。
Autophagy. 2021 Dec;17(12):4119-4140. doi: 10.1080/15548627.2021.1904489. Epub 2021 May 24.
9
Human-to-mouse prion-like propagation of mutant huntingtin protein.突变型亨廷顿蛋白的人源到小鼠的朊病毒样传播
Acta Neuropathol. 2016 Oct;132(4):577-92. doi: 10.1007/s00401-016-1582-9. Epub 2016 May 24.
10
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.用于亨廷顿舞蹈病中突变型亨廷顿蛋白体内成像的配体的开发。
Sci Transl Med. 2022 Feb 2;14(630):eabm3682. doi: 10.1126/scitranslmed.abm3682.

引用本文的文献

1
HTT loss-of-function contributes to RNA deregulation in developing Huntington's disease neurons.亨廷顿蛋白功能丧失导致亨廷顿病神经元发育过程中的RNA失调。
Cell Biosci. 2025 Jul 9;15(1):100. doi: 10.1186/s13578-025-01443-5.
2
Significance of gene therapy in neurodegenerative diseases.基因治疗在神经退行性疾病中的意义。
Front Neurosci. 2025 May 8;19:1515255. doi: 10.3389/fnins.2025.1515255. eCollection 2025.
3
AMPK Phosphorylates LMX1b to Regulate a Brainstem Neurogenic Network Important for Control of Breathing in Neonatal Mice.

本文引用的文献

1
Identifying the genes impacted by cell proliferation in proteomics and transcriptomics studies.在蛋白质组学和转录组学研究中识别受细胞增殖影响的基因。
PLoS Comput Biol. 2022 Oct 6;18(10):e1010604. doi: 10.1371/journal.pcbi.1010604. eCollection 2022 Oct.
2
JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.JASPAR 2022:转录因子结合谱开放获取数据库的第 9 个版本。
Nucleic Acids Res. 2022 Jan 7;50(D1):D165-D173. doi: 10.1093/nar/gkab1113.
3
Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases.
AMPK磷酸化LMX1b以调节对新生小鼠呼吸控制至关重要的脑干神经发生网络。
Int J Mol Sci. 2024 Dec 30;26(1):213. doi: 10.3390/ijms26010213.
4
Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review.神经退行性疾病基因治疗的进展与挑战:一项系统综述
Int J Mol Sci. 2024 Nov 21;25(23):12485. doi: 10.3390/ijms252312485.
5
Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity.橄榄苦苷增强蛋白酶体活性并降低突变型亨廷顿蛋白诱导的细胞毒性。
Front Pharmacol. 2024 Sep 13;15:1459909. doi: 10.3389/fphar.2024.1459909. eCollection 2024.
Rho家族小GTP酶在神经退行性疾病中的药理学调节剂
Front Cell Neurosci. 2021 May 12;15:661612. doi: 10.3389/fncel.2021.661612. eCollection 2021.
4
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice.纹状体注射胆固醇可促进亨廷顿病小鼠依赖剂量的行为获益,并发挥疾病修饰作用。
EMBO Mol Med. 2020 Oct 7;12(10):e12519. doi: 10.15252/emmm.202012519. Epub 2020 Sep 22.
5
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.亨廷顿病:分子发病机制和治疗机会的新见解。
Nat Rev Neurol. 2020 Oct;16(10):529-546. doi: 10.1038/s41582-020-0389-4. Epub 2020 Aug 14.
6
The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs.转录调控因子 ZNF398 在人多能干细胞中通过 TGF-β信号途径介导多能性和上皮特性。
Nat Commun. 2020 May 12;11(1):2364. doi: 10.1038/s41467-020-16205-9.
7
Whole brain delivery of an instability-prone transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome.全脑递送不稳定易位转基因可改善 Rett 综合征小鼠模型的行为和分子病理学缺陷。
Elife. 2020 Mar 24;9:e52629. doi: 10.7554/eLife.52629.
8
Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease.基因治疗将亨廷顿病小鼠模型纹状体星形胶质细胞转化为 GABA 能神经元。
Nat Commun. 2020 Feb 27;11(1):1105. doi: 10.1038/s41467-020-14855-3.
9
Iron homeostasis and oxidative stress: An intimate relationship.铁平衡和氧化应激:密切相关。
Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118535. doi: 10.1016/j.bbamcr.2019.118535. Epub 2019 Aug 22.
10
Causative Links between Protein Aggregation and Oxidative Stress: A Review.蛋白聚集与氧化应激之间的因果关系:综述。
Int J Mol Sci. 2019 Aug 9;20(16):3896. doi: 10.3390/ijms20163896.